AAMI ANSI/AAMI/ISO 22442-3:2007/(R)2016

Current Revision
Medical devices utilizing animal tissues and their derivatives—Part 3: Validation of the elimination and/or inactivation of viruses and transimissible spongiform encephalopathy (TSE) agents

Best Price Guarantee Jun 1, 2017 English 36 Pages

Sub Total (1 Item(s)) $ 0.00
Estimated Shipping $ 0.00
Total (Pre-Tax) $ 0.00

You own the digital copy of this edition

View in Library
or
Assoc. for the Advancement of Medical Instrumentation Logo

AAMI ANSI/AAMI/ISO 22442-3:2007/(R)2016

Medical devices utilizing animal tissues and their derivatives—Part 3: Validation of the elimination and/or inactivation of viruses and transimissible spongiform encephalopathy (TSE) agents

PUBLISH DATE 2017
AAMI ANSI/AAMI/ISO 22442-3:2007/(R)2016
Specifies requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in-vitro diagnostic medical devices) utilizing animal tissue or products derived from animal tissue, which are non-viable or have been rendered non-viable. Does not cover other transmissible and non-transmissible agents.
Loading...

Failed to load document history.

Publish Date Document Id Type View